一个基于证据的在线药物基因组学教育计划的可用性测试,用于在癌症护理中工作的药剂师
Benjamin Lee1, Georgia Bridges1, Chiao X Lim2
1Pharmacy Department, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, Victoria 3000, Australia.
Currents in pharmacy teaching & learning
|September 12, 2025
概括
这项研究评估了一项针对药剂师的在线药物基因组学教育计划,发现它是可以接受和有用的. 在更广泛实施之前,可用性测试为更好的用户体验提供了改进信息.
科学领域:
- 药物基因组学教育教育
- 医疗保健专业培训 医疗保健专业培训
- 可用性测试可用性测试
背景情况:
- 可用性测试对于验证新的教育计划至关重要.
- 为药剂师开发了一个内部,基于证据的药物基因组学教育计划.
- 该研究旨在在澳大利亚的一个瘤医院实施该程序之前评估和增强该程序的用户体验.
研究的目的:
- 评估在线药物基因组学教育计划的可用性.
- 确定用户体验需要改进的领域.
- 为药剂师确保计划的可接受性和有效性.
主要方法:
- 适应的方法从本尼迪克特等人. (2022年) 的第二季.
- 五名药剂师参与了这项研究,他们使用了八个模块的"大声思考"方法.
- 使用了定量工具 (SUS,SUPR-Q,WebQual) 和反射主题分析.
主要成果:
- 出现了四个主题:实用性,理解障碍和用户体验质量.
- 平均得分表明可用性很好:SUS (83.1),SUPR-Q (4.6),WebQual (6.1). 在这些中,平均得分表示可用性很好:SUS (83.1),SUPR-Q (4.6),WebQual (6.1).
- 药剂师发现内容有价值,格式有吸引力.
结论:
- 药物基因组学教育计划是可以接受的,有用的,并提供了积极的学习体验.
- 结果将指导程序修改以优化用户体验.
- 计划在推出后进行进一步的评估.
相关概念视频
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144


